QUINTESSENCE BIOSCIENCES
Quintessence Biosciences, Inc., a biopharmaceutical company, develops novel protein-based therapeutics as anti-cancer agents. The company’s products include Evade RNase QBI-139 that causes tumor growth inhibition in breast, colorectal, non-small cell lung, ovarian, pancreatic, and prostate cancers; targeted EVade ribonucleases, a tumor targeting therapy; and EVade ribonuclease zymogens that are inactive enzyme precursors that proteolytically cleave to manifest their catalytic activity. Its products are based on the Evade ribonuclease technology that allows for the engineering of human proteins (ribonucleases) for the treatment of human diseases.
QUINTESSENCE BIOSCIENCES
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2000-01-01
Address:
Madison, Wisconsin, United States
Country:
United States
Website Url:
http://www.quintbio.com
Total Employee:
11+
Status:
Closed
Contact:
6084412952
Email Addresses:
[email protected]
Total Funding:
3.13 M USD
Technology used in webpage:
Amazon Google Maps Google Maps API Amazon California Region
Current Employees Featured
Founder
Newest Events participated
Participated in AGC 13th Annual West Coast Technology Conference
on 2017-02-13 as exhibitor
Official Site Inspections
http://www.quintbio.com
- Host name: 104.21.12.178
- IP address: 104.21.12.178
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Quintessence Biosciences"
Quintessence Biosciences - Crunchbase Company …
Quintessence Biosciences, Inc., a biopharmaceutical company, develops novel protein-based therapeutics as anti-cancer agents. The company’s products …See details»
QuintBio - Company Profile - Tracxn
QuintBio. has raised a total funding of $1.49M over 1 round. List of recent funding rounds of QuintBio. Date of funding. Funding Amount. Round Name. Post money valuation. Revenue …See details»
Quintessence Biosciences Inc. - life-sciences-usa.com
Jan 1, 2008 https://www.quintbio.com Quintessence Biosciences, Inc. is a private biopharmaceutical company focused on development of proprietary cancer therapies based on …See details»
Quintessence Biosciences - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Quintessence Biosciences. Use the PitchBook Platform to explore the full profile.See details»
Quintessence Biosciences, Inc. Overview - SignalHire
Quintessence Biosciences, Inc. is a biopharmaceutical company focused on development of novel protein-based therapeutics as anti-cancer agents. The Company’s products are based on the …See details»
Quintessence Biosciences - Owler
Jan 5, 2017 Quintessence Biosciences’s Profile, Revenue and Employees. Quintessence Biosciences is a biopharmaceutical firm focused on the development of novel protein drugs for …See details»
QUINTESSENCE BIOSCIENCES, INC. - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
This week our shareholders... - Quintessence Biosciences - Facebook
Apr 14, 2012 This week our shareholders elected Walter Dewey to join our Board of Directors. We're looking forward to working with him!See details»
QuintBio - Raised $1.49M Funding from 1 investor - Tracxn
Feb 10, 2025 QuintBio has raised a total funding of $1.49M over 1 round from 1 investor. Investor includes Springboard Enterprises. Their latest funding round was of $1.49M on Jun …See details»
Home - Quint
It supports selection, development, micro -organization decisions; Allows monitoring of the results of the actions taken; Discover Pico. From an accurate data analysis comes the path that …See details»
Quintessence Biosciences, Inc. (Quintessence Biosciences, Inc.) - 药 …
A review.PreserveX polymeric micelles support both membrane protein purification and stabilization.The resulting stabilized membrane proteins can be used for crystallog., MS, and …See details»
Quintessence Biosciences, Inc. Presents Efficacy Data for
The company also has a pipeline of other EVade™ Ribonuclease products in preclinical research. For more information, visit www.quintbio.com. About the International Conference on …See details»
Executive Q&A: Quintessence Biosciences CEO creates company …
Sep 22, 2012 A: Quintessence Biosciences, or Quint Bio, is a very interesting company. And the business model of drug development is a very interesting model. The business model poses …See details»
Quintessence will be at the BIO... - Quintessence Biosciences
Quintessence will be at the BIO International Convention in San Diego soon! In addition to the partnering system, we would be happy to discuss our cancer drug development programs at …See details»
Quintbio : quintbio.com
Quintbio.com is 2 decades 3 years old. It is a domain having com extension. This website is estimated worth of $ 8.95 and have a daily income of around $ 0.15. As no active threats were …See details»
Our EVade™ RNases | Quintessence Biosciences, Inc.
Quintessence Biosciences has capitalized on the serendipitous discovery that a frog ribonuclease, an enzyme that degrades RNA, is naturally toxic to cancer cells. By exploring the underlying …See details»
Quinte Health Functional Organizational Chart
Quinte Health Organization Chart – Program Leadership . Lina Rinaldi Vice President & CNE Dr. Colin MacPherson Chief of Staff Matthew Campbell, Vice President & CTO Board of Directors …See details»
QuintBio (@QuintBio) - Twitter
Aug 11, 2015 The latest Tweets from QuintBio (@QuintBio). Quintessence Biosciences is a clinical stage biopharmaceutical company developing novel anti-cancer compounds based on …See details»
Team | Brasswater Inc.
She is responsible for all aspects of finance, treasury, financial reporting, tax planning, human resources and Information Technology for the organization. She conceives and implements …See details»
Quinte Health joining forces with other organizations for new …
The organization that runs four local hospitals in Quinte has joined forces with five others on a new health information system. The system, called Lumeo, was developed by six partners with …See details»